Thyroid Hormone Replacement Therapy

Overview

Thyroid hormone replacement therapy is the use of synthetic thyroid hormone, most commonly levothyroxine, to restore normal circulating thyroid hormone levels in people whose thyroid gland produces too little. It is the standard treatment for hypothyroidism, whether arising from autoimmune disease, thyroid surgery, radioactive iodine treatment, or other causes, and it is essential after thyroidectomy for Thyroid Cancer, where lifelong hormone supplementation maintains metabolic function and, in some protocols, suppresses thyroid-stimulating hormone to reduce cancer recurrence risk. Thyroid hormones regulate metabolism, energy, growth, mood, and cardiovascular function, so adequate replacement supports normal physiology, while dosing must be monitored to avoid under- or over-treatment. The journal Thyroid Cancer publishes peer-reviewed research on the diagnosis, surgical and radioactive-iodine management, and long-term outcomes of thyroid malignancies, the clinical context in which hormone replacement after thyroidectomy is routinely required. Related work in the journal addresses treatment outcomes in differentiated Thyroid Cancer following surgery and radioiodine, and radiation safety after radioiodine ablation. This page gathers open-access scholarship relevant to Thyroid Cancer care, within which thyroid hormone replacement is a continuing component of patient management.

Research published in this journal

5 peer-reviewed articles, ranked by relevance. Each links to its DOI.

How this research is being cited

The 5 articles above have been cited 8 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.

• Measurement of Radiation Exposure to Caregivers of Patients with Thyroid Diseases Treated with Iodine-131: A Review
  Ali Abdulhasan Kadhim et al. · 2020 ·
• Radiation Dose Assessment to Family Members Taking Care of Non-Cancerous Thyroid Patients Treated with I-131 Therapy in Nuclear Medicine Department.
  Ali Abdulhasan Kadhim et al. · 2020 · Radiation Protection Dosimetry
• Measurement of cumulative radiation exposure to children and adolescents in contact with outpatients treated with low dose radioactive iodine (131I)
  K. Salman et al. · 2020 · Journal of the Egyptian National Cancer Institute
• Measurement of cumulative radiation exposure to children and adolescents in contact with outpatients treated with low dose radioactive iodine (131I)
  2020 · Journal of the Egyptian National Cancer Institute
• RADIATION DOSE ASSESSMENT TO FAMILY MEMBERS TAKING CARE OF NON-CANCEROUS THYROID PATIENTS TREATED WITH I-131 THERAPY IN NUCLEAR MEDICINE DEPARTMENT
  2020 · Radiation Protection Dosimetry
• Measurement of radiation exposure to household contacts of patients with Graves’ disease treated with low dose radioactive iodine (131I) on outpatient basis
  K. Salman et al. · 2018 · The Egyptian Journal of Radiology and Nuclear Medicine
• Measurement of External Radiation Exposure to Household Contacts of Outpatients Treated with Radioactive Iodine (131I).
  Salman et al. · 2018 ·
• Measurement of radiation exposure to household contacts of patients with Graves’ disease treated with low dose radioactive iodine (131I) on outpatient basis
  2018 · The Egyptian Journal of Radiology and Nuclear Medicine

A sample of recent works citing this journal's research on Thyroid Hormone Replacement Therapy, linking to each citing work.

This page summarises published research for orientation; it is not medical or professional advice.

Related topics